Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.

@article{Schuett2007IfosfamideEC,
  title={Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.},
  author={Philipp Schuett and J Passon and Peter Ebeling and Anja Welt and Stefan M{\"u}ller and Klaus Metz and Thomas Moritz and Siegfried Seeber and M R Nowrousian},
  journal={European journal of haematology},
  year={2007},
  volume={78 2},
  pages={93-101}
}
High-dose chemotherapy (HD-CT) with autologous stem cell transplantation is considered to be the treatment of choice for relapsed high-grade non-Hodgkin's lymphoma (NHL) and Hodgkin's lymphoma (HL) patients, but the optimal treatment has not yet been defined. We evaluated a salvage treatment regimen consisting of conventional cycles with ifosfamide, etoposide, cytarabine, and dexamethasone (IVAD) followed by two cycles of HD-CT consisting of cyclophosphamide, melphalan, and etoposide (CMV) with… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

[Ifosphamide nephrotoxicity].

Nephrologie & therapeutique • 2018
View 3 Excerpts
Highly Influenced

Autologous Hematopoietic Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma.

Journal of clinical and experimental hematopathology : JCEH • 2016

Similar Papers

Loading similar papers…